Heather Lau, M.D. M.S. is a board certified neurologist with special qualifications in child neurology and recently joined Ultragenyx as Executive Director of Global Clinical Development, where she will lead efforts to develop new therapies for a range of neurologic diseases.
Dr. Lau received her bachelor of science with honors from Cornell University and a master of science in biochemistry and molecular biology from New York Medical College. She went on to receive her doctorate of medicine from the University of Rochester. She trained in pediatrics at Montefiore Medical Center and completed her child neurology training as well as additional fellowship training in Neurogenetics from New York University.
Dr. Lau was assistant professor in Child Neurology at NYU School of Medicine and had been the Director of the NYU Lysosomal Storage Disorders Program at NYU Langone Health for 8 years and associate director of the Division of Neurogenetics. She maintained a large and diverse practice of patients with rare, inherited disorders of the nervous system with a special interest in lysosomal storage disorders, ataxias, and leukodystrophies.
Dr. Lau is now an adjunct assistant professor at Yale University in the Lysosomal Program in the Department of Internal Medicine continuing her efforts in rare disease research alongside Dr. Pramod Mistry. Throughout her academic career, Dr. Lau had been actively engaged in clinical research and a principal investigator for over 40 clinical interventional trials and disease registries evaluating enzyme replacement therapies, small molecules, and gene therapy.
